# Denosumab and Screw Fixation for Osteoporotic Compression Fracture

> **NCT05065164** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Shenzhen People's Hospital**

## Conditions studied

- Denosumab Allergy

## Interventions

- **DRUG:** Denosumab Only Product

## Key facts

- **NCT ID:** NCT05065164
- **Lead sponsor:** Shenzhen People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-09-14
- **Primary completion:** 2023-03-20
- **Final completion:** 2023-09-25
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no partcipants enrolled
- **Last updated:** 2023-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05065164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05065164, "Denosumab and Screw Fixation for Osteoporotic Compression Fracture". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05065164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*